Skip to main content

Table 5 Proportion of study participants with fever, parasitemia and adherence on D3 of study

From: Effectiveness and safety of artesunate–amodiaquine versus artemether–lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6–120 months in Yaoundé, Cameroon: a randomized trial

Characteristic/category

AS-AQ (%)

AL (%)

P-value*

 

n = 101

n = 115

 

Proportion of fever on D3

   

 Yes

8 (7.9)

16 (13.9)

0.162

 No

93 (92.1)

99 (86.1)

 

Proportion of parasitemia on day 3

   

 Yes

31 (30.7)

30 (26.1)

0.453

 No

70 (69.3)

85 (73.9)

 

Adherence to treatment guideline

   

 Yes

100 (99.0)

115 (99.1)

1.000

 No

1 (1.0)

1 (0.9)

 
  1. n  Sample size, *Determined using Pearson chi-square test or Fisher’s exact test for categorical variables, Only participants who came for the day 3 visit post-treatment were included in the analyses, Participants were excluded from analyses if they vomited the study drug more than once, violated enrollment criteria, were lost-to-follow-up or withdrew from the study before day 3